CVS Health opened its first pharmacy-focused CVS Pharmacy in the Boston area in early October 2026 and outlined plans for nearly 20 smaller neighborhood pharmacies nationwide in 2026, part of a broader realignment of its retail footprint that also includes store-in-store locations and clinics. At the same time, the company's Aetna unit is contending with updated Medicare Advantage star ratings that affect quality bonus eligibility, a reset the article describes as material for near-term earnings sensitivity. The new Boston-area pharmacy and the nearly 20 planned sites tie directly into CVS Health's push to reinforce core pharmacy economics and care access, alongside an extended Cardinal Health distribution agreement through 2032 and ongoing store-in-store expansion. The article's narrative projects $458.7 billion in revenue and $11.3 billion in earnings by 2029, requiring 3.6% yearly revenue growth and a $6.4 billion earnings increase from $4.9 billion today, and yields a $116.28 fair value representing 35% upside to the current price. Five members of the Simply Wall St Community see CVS Health's fair value between US$104.01 and US$273.65.
CVS Health CorpCVS opened its first Boston-area pharmacy and plans nearly 20 more neighborhood pharmacies in 2026, reinforcing core pharmacy economics and care access.
Cardinal Health IncCVS extended its Cardinal Health distribution agreement through 2032, supporting Cardinal's supply relationship.
